Stay updated on Benralizumab for Severe Nasal Polyposis Clinical Trial

Sign up to get notified when there's something new on the Benralizumab for Severe Nasal Polyposis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab for Severe Nasal Polyposis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 in the page footer.
    Difference
    0.0%
    Check dated 2026-03-07T19:35:41.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 instead of Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T04:26:25.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0, which appears to be a minor UI/version update and does not affect the study details or user tasks on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T02:58:30.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A glossary display option was added, along with new metadata labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.1%
    Check dated 2026-01-23T20:15:00.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-17T01:12:57.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites across Alabama, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Maryland, Massachusetts, Minnesota, Nebraska, New York, North Carolina, Oklahoma, Pennsylvania, South Carolina, Texas, Utah, Virginia, Washington, and Canadian provinces (British Columbia, Ontario, Quebec). Removed HHS Vulnerability Disclosure and updated the page revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-19T06:55:48.000Z thumbnail image

Stay in the know with updates to Benralizumab for Severe Nasal Polyposis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab for Severe Nasal Polyposis Clinical Trial page.